168 related articles for article (PubMed ID: 21605663)
1. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
[TBL] [Abstract][Full Text] [Related]
2. Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis.
Alexoudi A; Zachaki S; Stavropoulou C; Chatzi I; Koumbi D; Stavropoulou K; Kollia P; Karageorgiou CE; Sambani C
Int J Neurosci; 2015 Jan; 125(1):32-7. PubMed ID: 24588223
[TBL] [Abstract][Full Text] [Related]
3. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
[TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
6. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
[TBL] [Abstract][Full Text] [Related]
7. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
8. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
9. Association of C609T-Inborn Polymorphism of NAD(P)H: Quinone Oxidoreductase 1 with the Risk of Bronchopulmonary Dysplasia in Preterm Neonates.
Gavrili S; Zachaki S; Daraki A; Polycarpou E; Manola K; Stavropoulou C; Sambani C; Baroutis G
Am J Perinatol; 2016 May; 33(6):535-9. PubMed ID: 26683602
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer].
Chen DJ; Ding R; Cao W; Ye DQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):5-8. PubMed ID: 21518531
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes.
Ramprasath T; Murugan PS; Kalaiarasan E; Gomathi P; Rathinavel A; Selvam GS
Mol Cell Biochem; 2012 Feb; 361(1-2):143-50. PubMed ID: 21989715
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
13. Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues.
Tseng LM; Yin PH; Tsai YF; Chi CW; Wu CW; Lee LM; Lee HC
Oncol Rep; 2009 May; 21(5):1169-74. PubMed ID: 19360290
[TBL] [Abstract][Full Text] [Related]
14. Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis.
Alexoudi A; Zachaki S; Stavropoulou C; Gavrili S; Spiliopoulou C; Papadodima S; Karageorgiou CE; Sambani C
Ann Clin Lab Sci; 2016 Dec; 46(6):586-591. PubMed ID: 27993870
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
16. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
[TBL] [Abstract][Full Text] [Related]
18. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
